Medical treatments of endometriosis: a review

Bahi Elbasueny; Maya Geerts; Emily C. Yang; Catherine Allaire; Paul J. Yong; Mohamed A. Bedaiwy

doi:10.1097/rd9.0000000000000053

Medical treatments of endometriosis: a review

Bahi Elbasueny, Maya Geerts, Emily C. Yang, Catherine Allaire, Paul J. Yong, Mohamed A. Bedaiwy

In: Reproductive and Developmental Medicine · 2022 · vol. 7(3) , pp. 166–179 · doi:10.1097/rd9.0000000000000053 · W4308733170

review OA: diamond CC0 ⤵ 4 in-corpus citations

🔓 Open OA copy View on OpenAlex View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This review synthesizes current and investigational medical therapies for endometriosis pain, detailing a symptom-based approach and recommending future research directions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a chronic gynecological disorder that affects approximately 10% of women of reproductive age. Most medical treatments used today for endometriosis pain are hormonal therapies, which are not an option for those trying to conceive and are not tolerated by a subset of patients due to side effects. In this article, we offer a comprehensive review of current and investigational medical therapeutic options used to treat endometriosis pain, as well as a symptom-based systematic approach for patients with painful endometriosis. We have also included recommendations for research to enhance the evolution of novel therapeutic options. A thorough literature search was carried out, and the data were synthesized using a synthesis matrix that classifies and categorizes various arguments.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (100)

Cited by (4)

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00

License: CC0 · commercial use OK

[1] A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis via openalex

[2] Adenoviral vector encoding soluble Flt-1 engineered human endometrial mesenchymal stem cells effectively regress endometriotic lesions in NOD/SCID mice via openalex

[3] Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain via openalex

[4] An evidence‐based approach to assessing surgical versus clinical diagnosis of symptomatic endometriosis via openalex

[5] A New Therapy for Pelvic Endometriosis and Uterine Adenomyosis: Local Effect of Vaginal and Intrauterine Danazol Application via openalex

[6] A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model via openalex

[7] Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model via openalex

[8] Antifibrotic properties of epigallocatechin-3-gallate in endometriosis via openalex

[9] A peek into the drug development scenario of endometriosis – A systematic review via openalex

[10] Application of the nuclear factor-κB inhibitor BAY 11-7085 for the treatment of endometriosis: an in vitro study via openalex

[11] Application of the nuclear factor-κB inhibitor pyrrolidine dithiocarbamate for the treatment of endometriosis: an in vitro study via openalex

[12] A Promise in the Treatment of Endometriosis: An Observational Cohort Study on Ovarian Endometrioma Reduction by N-Acetylcysteine via openalex

[13] ASSESSMENT OF COMMON ADVERSE EVENTS OF RELUGOLIX COMBINATION THERAPY IN PREMENOPAUSAL WOMEN TREATED FOR SYMPTOMATIC ESTROGEN-DRIVEN CONDITIONS: LIBERTY AND SPIRIT STUDIES via openalex

[14] Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies via openalex

[15] Clinical diagnosis of endometriosis and optimal medical therapy via openalex

[16] Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis via openalex

[17] Clinical Evaluation of the Oral Gonadotropin-Releasing Hormone-Antagonist Elagolix for the Management of Endometriosis-Associated Pain via openalex

[18] Committee Opinion No. 663 via openalex

[19] Complications, pregnancy and recurrence in a prospective series of 500 patients operated on by the shaving technique for deep rectovaginal endometriotic nodules via openalex

[20] Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis via openalex

[21] Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review via openalex

[22] Costunolide Induces Apoptosis in Human Endometriotic Cells through Inhibition of the Prosurvival Akt and Nuclear Factor Kappa B Signaling Pathway via openalex

[23] Current and Emerging Therapeutics for the Management of Endometriosis via openalex

[24] Current status and challenges of drug development for hormonal treatment of endometriosis: a systematic review of randomized control trials via openalex

[25] Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis via openalex

[26] Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis via openalex

[27] Development of an intravaginal ring delivering simultaneously anastrozole and levonorgestrel: a pharmacokinetic perspective via openalex

[28] Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences via openalex

[29] Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study via openalex

[30] Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment via openalex

[31] Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis via openalex

[32] Drug delivery for the treatment of endometriosis and uterine fibroids via openalex

[33] Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data via openalex

[34] Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model via openalex

[35] Effect of Vascular Endothelial Growth Factor Inhibition on Endometrial Implant Development in a Murine Model of Endometriosis via openalex

[36] Effects of an extended-interval dosing regimen of triptorelin depot on the hormonal profile of patients with endometriosis: prospective observational study. via openalex

[37] Effects of different add-back regimens on hypoestrogenic problems by postoperative gonadotropin-releasing hormone agonist treatment in endometriosis via openalex

[38] Effects of etonogestrel implant on quality of life, sexual function, and pelvic pain in women suffering from endometriosis: results from a multicenter, prospective, observational study via openalex

[39] Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis via openalex

[40] Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia via openalex

[41] Effects of long-term postoperative dienogest use for treatment of endometriosis on bone mineral density via openalex

[42] Effects of Pazopanib, Sunitinib, and Sorafenib, Anti-VEGF Agents, on the Growth of Experimental Endometriosis in Rats via openalex

[43] Efficacies of vitamin D and omega-3 polyunsaturated fatty acids on experimental endometriosis via openalex

[44] Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis via openalex

[45] EFFICACY AND SAFETY OF RELUGOLIX COMBINATION THERAPY IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN: PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (SPIRIT 2) via openalex

[46] Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats via openalex

[47] Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model via openalex

[48] Efficacy of elagolix in the treatment of endometriosis via openalex

[49] Efficacy of imiquimod, an immunomodulatory agent, on experimental endometriosis via openalex

[50] Efficacy of ten interventions for endometriosis: A network meta‐analysis via openalex

[51] Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis via openalex

[52] Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density via openalex

[53] Elagolix for endometriosis: all that glitters is not gold via openalex

[54] Elagolix in the treatment of endometriosis: impact beyond pain symptoms via openalex

[55] Endometrial cells contribute to preexisting endometriosis lesions in a mouse model of retrograde menstruation† via openalex

[56] Endometriosis a brief review: evaluation of crucial risk factors and current treatment regimes via openalex

[57] Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review via openalex

[58] Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months via openalex

[59] Endometriosis: Diagnosis and Management via openalex

[60] Endometriosis Pain Management: a Review via openalex

[61] Endometriosis with infertility: A comprehensive review on the role of immune deregulation and immunomodulation therapy via openalex

[62] Epidemiology of endometriosis in women attending family planning clinics. via openalex

[63] Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo via openalex

[64] Estrogen-progestins and progestins for the management of endometriosis via openalex

[65] Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial via openalex

[66] Evaluation of the efficacy of a danazol-loaded intrauterine contraceptive device on adenomyosis in an ICR mouse model via openalex

[67] Extrapelvic Endometriosis: A Systematic Review via openalex

[68] From pathogenesis to clinical practice: Emerging medical treatments for endometriosis via openalex

[69] Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex

[70] Gonadotropin-releasing hormone agonist plus “add-back” hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial via openalex

[71] Hormonal therapy for endometriosis: from molecular research to bedside via openalex

[72] Human chorionic gonadotrophin attenuates NF-κB activation and cytokine expression of endometriotic stromal cells via openalex

[73] Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference via openalex

[74] Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study via openalex

[75] Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques via openalex

[76] In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells via openalex

[77] Levonorgestrel‐releasing intrauterine system (Mirena <sup>®</sup> ) and Depot medroxyprogesterone acetate (Depoprovera) as long‐term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial via openalex

[78] Long‐term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta‐analysis via openalex

[79] Long-Term Outcomes of Elagolix in Women With Endometriosis via openalex

[80] Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex

[81] Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain via openalex

[82] Medical management of endometriosis via openalex

[83] Medical Management of Endometriosis via openalex

[84] Medical Therapy of Endometriosis via openalex

[85] Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials via openalex

[86] Medical Treatment for Endometriosis: Tolerability, Quality of Life and Adherence via openalex

[87] Medical treatment of endometriosis-related pain via openalex

[88] Medical Treatments for Endometriosis-Associated Pelvic Pain via openalex

[89] Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9 via openalex

[90] Mifepristone 2.5, 5, 10mg versus placebo in the treatment of endometriosis via openalex

[91] miR-503, a microRNA epigenetically repressed in endometriosis, induces apoptosis and cell-cycle arrest and inhibits cell proliferation, angiogenesis, and contractility of human ovarian endometriotic stromal cells via openalex

[92] Müllerianosis: Four Developmental (Embryonic) Müllerian Diseases via openalex

[93] Nanoparticle-Assisted Combinatorial Therapy for Effective Treatment of Endometriosis via openalex

[94] New developments in the medical treatment of endometriosis via openalex

[95] Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate via openalex

[96] Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis via openalex

[97] Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study via openalex

[98] Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique®) in the treatment of endometriosis symptoms: A prospective open-label comparative study via openalex

[99] Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis via openalex

[100] Omega 3 Fatty Acids Counteract IL-8 and Prostaglandin E2 Secretion Induced by TNF-α in Cultured Endometrial Stromal Cells via openalex